TSH 9 mIU/L with Normal T3/T4 - Subclinical Hypothyroidism
This is subclinical hypothyroidism (SCH). The TSH of 9 falls in the 5-10 mIU/L range, which is below the threshold of 10 most guidelines use for automatic treatment. The decision to start thyroxine is not automatic - it depends on several factors.
The Key Threshold: TSH >10 mIU/L
Most authorities agree that TSH >10 mIU/L is a clear indication to treat, regardless of symptoms. At TSH = 9, you are just below this threshold, so treatment is NOT mandatory but may still be appropriate depending on the clinical context.
When to START Thyroxine (Even with TSH 5-10)
According to Goldman-Cecil Medicine and The Washington Manual, treat subclinical hypothyroidism if any of the following are present:
- Symptoms compatible with hypothyroidism (fatigue, weight gain, cold intolerance, constipation, dry skin, cognitive slowing)
- Goiter present on examination
- Hypercholesterolaemia that warrants treatment (SCH raises LDL; levothyroxine may lower it)
- Thyroid peroxidase antibodies (TPOAb) positive - indicates underlying Hashimoto thyroiditis with likely progression to overt hypothyroidism
- Pregnancy or planning pregnancy - treat if TSH is above trimester-specific ranges with TPOAb, or if TSH >10 regardless. Untreated SCH in pregnancy risks fetal neurological harm
- Assisted reproduction / fertility treatment - levothyroxine improves live birth rates in this population
When to DEFER and Monitor
If the patient is:
- Asymptomatic
- Elderly (>65 years) - evidence does NOT show benefit in quality of life or symptoms in this age group; treatment may increase cardiovascular risk from over-replacement
- No goiter, normal lipids, TPOAb negative
Then a reasonable approach is:
- Recheck TSH and free T4 annually
- Start thyroxine only if TSH rises above 10 or symptoms develop
Practical Summary
| Factor | Action |
|---|
| TSH 9 + symptoms | Start levothyroxine |
| TSH 9 + TPOAb positive | Strongly consider treatment |
| TSH 9 + pregnancy/fertility | Start levothyroxine |
| TSH 9 + hypercholesterolaemia | Start levothyroxine |
| TSH 9 + age >65, asymptomatic | Defer, monitor annually |
| TSH 9 + asymptomatic, young/middle-aged | Clinical judgement; many clinicians treat |
Dosing if started: Begin at a low dose (25-50 mcg/day in elderly or those with cardiac disease; 50-75 mcg/day in otherwise healthy adults), recheck TSH in 6-8 weeks, and titrate to a target TSH of 0.5-2.5 mIU/L. Avoid over-replacement (suppressed TSH) as it raises the risk of atrial fibrillation and bone loss.
Bottom line: A TSH of 9 with normal free T3/T4 does not automatically require treatment. However, the presence of symptoms, positive TPOAb, goiter, high cholesterol, or pregnancy tips the balance firmly toward starting levothyroxine. Confirm the TSH on a repeat test (ideally 3 months apart) before committing to lifelong therapy if the patient is asymptomatic.
Sources: Goldman-Cecil Medicine, Washington Manual of Medical Therapeutics; also supported by recent meta-analyses (PMID 38368537, PMID 38676741) showing levothyroxine benefit specifically in fertility/pregnancy outcomes in SCH.